Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences

Samankaltaisia teoksia

• Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2011)
• Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-κB–Dependent Pathway
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2007)
• GENE TRANSFER OF INDUCIBLE NITRIC OXIDE SYNTHASE AFFORDS CARDIOPROTECTION BY UPREGULATING HEME OXYGENASE-1 VIA AN NF-κB-DEPENDENT PATHWAY
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2009)
• Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models
  Tekijä: Li, Qianhong, et al.
  Julkaistu: (2011)
• Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min
  Tekijä: Tang, Xian-Liang, et al.
  Julkaistu: (2006)